Single Injection of High Volume of Autologous Pure PRP Provides a Significant Improvement in Knee Osteoarthritis: A Prospective Routine Care Study

Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activi...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 20; no. 6; p. 1327
Main Authors Guillibert, Caroline, Charpin, Caroline, Raffray, Marie, Benmenni, Annie, Dehaut, Francois-Xavier, El Ghobeira, Georges, Giorgi, Roch, Magalon, Jeremy, Arniaud, Denis
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 15.03.2019
MDPI
Subjects
Online AccessGet full text
ISSN1422-0067
1661-6596
1422-0067
DOI10.3390/ijms20061327

Cover

Abstract Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure. Methods: Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria. Results: A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters. Conclusion: A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital.
AbstractList Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure. Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria. A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure ( < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 ( < 0.001). No difference was observed on MRI parameters. A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital.
Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure. Methods: Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria. Results: A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters. Conclusion: A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital.
Among them, platelet-rich plasma (PRP) is defined as an autologous plasma suspension of platelets, characterized by a platelet concentration higher than in physiological blood [9] and able to release growth factors (GFs) involved in reparative and regenerative processes. PRP has been the subject of increased clinical interest in the orthopaedic field and a recent meta analysis indicates that, compared with HA and saline, an intra-articular PRP injection may have more benefits in pain relief and functional improvement in patients with symptomatic knee OA at one year post-injection [10], providing orthopaedic surgeons and rheumatologists a new validated non-invasive option to improve knee OA related symptoms [11]. Substantial differences in the content of platelets concentrates produced by the various automated and manual protocols have been described [12,13] and their consequences on clinical results in PRP therapy is currently being investigated [14,15]. [...]the initiation of PRP injection activity within a hospital necessitates the selection of dedicated material and the establishment of a precise patient care procedure which should take into account recent recommendations from the AAOS regarding minimum reporting standards for clinical studies evaluating PRP [16]. [...]the medical device used in this study was validated in order to reach this condition.
Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure. Methods: Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria. Results: A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure ( p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 ( p < 0.001). No difference was observed on MRI parameters. Conclusion: A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital.
Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure.BACKGROUNDEvidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis (OA). However, heterogeneity in common practice regarding PRP preparation and biological content makes the initiation of this activity in a hospital complex. The aim of this study was to document the efficacy of a single PRP injection to treat knee OA and validate a routine care procedure.Fifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria.METHODSFifty-seven patients with symptomatic knee OA received a single injection of large volume of very pure PRP. They were assessed at baseline and after one, three and six months, by measuring Knee Injury and Osteoarthritis Score (KOOS), Observed Pain after a 50-foot walk test and Visual Analog Scale (VAS) assessments. Magnetic Resonance Imaging (MRI) analysis was performed at baseline and six months after the procedure. The objective was to recover 50% of responders three months after the procedure using OMERACT-OARSI criteria.A single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters.RESULTSA single administration of high volume pure PRP provided significant clinical benefit for 84.2% of the responders, three months after the procedure. The KOOS total score significantly increased from 43.5 ± 14.3 to 66.4 ± 21.7 six months after the procedure (p < 0.001). Pain also significantly decreased from 37.5 ± 25.1 to 12.9 ± 20.9 (p < 0.001). No difference was observed on MRI parameters.A single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital.CONCLUSIONA single injection of large volume of very pure PRP is associated with significant functional improvement and pain relief, allowing initiation of daily PRP injection within our hospital.
Author Charpin, Caroline
Benmenni, Annie
Raffray, Marie
Dehaut, Francois-Xavier
Giorgi, Roch
Arniaud, Denis
Magalon, Jeremy
Guillibert, Caroline
El Ghobeira, Georges
AuthorAffiliation 4 Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Sciences Economiques et Sociales de la Santé & Traitement de l’Information Médicale, Hop Timone, BioSTIC, Biostatistique et Technologies de l’Information et de la Communication, 13005 Marseille, France; Roch.GIORGI@ap-hm.fr
1 Rheumatology Department, Hôpital Saint Joseph, 13008 Marseille, France; cguillibert@hopital-saint-joseph.fr (C.G.); ccharpin@hopital-saint-joseph.fr (C.C.); mraffray@hopital-saint-joseph.fr (M.R.); anbenmenni@hopital-saint-joseph.fr (A.B.); darniaud@hopital-saint-joseph.fr (D.A.)
3 Physical Therapy Department, Hôpital Saint Joseph, 13008 Marseille, France; gelghobeira@hopital-saint-joseph.fr
5 Cell Therapy Department, Hôpital de la Conception, AP-HM, INSERM CIC BT 1409, 13005 Marseille, France
2 Radiology Department, Hôpital Saint Joseph, 13008 Marseille, France; fxdehaut@hopital-saint-joseph.fr
AuthorAffiliation_xml – name: 5 Cell Therapy Department, Hôpital de la Conception, AP-HM, INSERM CIC BT 1409, 13005 Marseille, France
– name: 1 Rheumatology Department, Hôpital Saint Joseph, 13008 Marseille, France; cguillibert@hopital-saint-joseph.fr (C.G.); ccharpin@hopital-saint-joseph.fr (C.C.); mraffray@hopital-saint-joseph.fr (M.R.); anbenmenni@hopital-saint-joseph.fr (A.B.); darniaud@hopital-saint-joseph.fr (D.A.)
– name: 3 Physical Therapy Department, Hôpital Saint Joseph, 13008 Marseille, France; gelghobeira@hopital-saint-joseph.fr
– name: 4 Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Sciences Economiques et Sociales de la Santé & Traitement de l’Information Médicale, Hop Timone, BioSTIC, Biostatistique et Technologies de l’Information et de la Communication, 13005 Marseille, France; Roch.GIORGI@ap-hm.fr
– name: 2 Radiology Department, Hôpital Saint Joseph, 13008 Marseille, France; fxdehaut@hopital-saint-joseph.fr
Author_xml – sequence: 1
  givenname: Caroline
  surname: Guillibert
  fullname: Guillibert, Caroline
– sequence: 2
  givenname: Caroline
  surname: Charpin
  fullname: Charpin, Caroline
– sequence: 3
  givenname: Marie
  surname: Raffray
  fullname: Raffray, Marie
– sequence: 4
  givenname: Annie
  surname: Benmenni
  fullname: Benmenni, Annie
– sequence: 5
  givenname: Francois-Xavier
  surname: Dehaut
  fullname: Dehaut, Francois-Xavier
– sequence: 6
  givenname: Georges
  surname: El Ghobeira
  fullname: El Ghobeira, Georges
– sequence: 7
  givenname: Roch
  surname: Giorgi
  fullname: Giorgi, Roch
– sequence: 8
  givenname: Jeremy
  orcidid: 0000-0003-1494-7011
  surname: Magalon
  fullname: Magalon, Jeremy
– sequence: 9
  givenname: Denis
  surname: Arniaud
  fullname: Arniaud, Denis
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30884774$$D View this record in MEDLINE/PubMed
https://inserm.hal.science/inserm-02551116$$DView record in HAL
BookMark eNptUk2P0zAQtdAi9gNunJElLhwoxB9JGg5IVQW0otJWW-BqOc44dZXYXduptH-DX4yj7i5lxWlmNG_ezJuZS3RmnQWEXpPsA2NV9tHs-kCzrCCMls_QBeGUTlJYnp345-gyhF2WUUbz6gU6Z9l0ysuSX6DfG2PbDvDS7kBF4yx2Gi9Mu8W_XDf0MIazIbrOtW4IeD14wOubNV57dzANBCzxxrTWaKOkjXjZ71MCeki-sfi7BcDXIYKTPm69iSZ8wrOxOOzHdgfAN26IxgKey8S8iUNz9xI917IL8OreXqGfX7_8mC8mq-tvy_lsNVGcV3ECjORFU-iq5lznU6Y0T-IYUYVUU5LXJaOsBimnnOq8bipVQ14yXTCdlFfJvUKfj7z7oe6hUWlmLzux96aX_k44acS_GWu2onUHUfCSkqpIBO-PBNsnZYvZShgbwPcio3lOCCkOJMHf3ffz7naAEEVvgoKukxbSbkXi5ITlySTo2yfQnRu8TdsQlLGEKAlhCfXmVMDjCA_XTQB6BKi08OBBC2WiHK-c9JhOkEyMLyROX-ivqseiB97_wv8AikzJEw
CitedBy_id crossref_primary_10_3390_ijms21041328
crossref_primary_10_7759_cureus_10575
crossref_primary_10_24938_kutfd_693499
crossref_primary_10_1155_2021_8808310
crossref_primary_10_3390_jpm13091309
crossref_primary_10_1007_s00266_022_02960_1
crossref_primary_10_1007_s00167_020_06102_5
crossref_primary_10_1016_j_arthro_2024_03_030
crossref_primary_10_1016_j_arthro_2021_03_074
crossref_primary_10_4103_jmupm_jmupm_3_23
crossref_primary_10_7759_cureus_70059
crossref_primary_10_1007_s12178_019_09573_3
crossref_primary_10_3390_jcm11082231
crossref_primary_10_1080_09537104_2020_1832653
crossref_primary_10_1177_1759720X221100304
crossref_primary_10_2147_JPR_S260878
crossref_primary_10_3390_bioengineering10080922
crossref_primary_10_1007_s11655_025_4208_z
crossref_primary_10_1111_ijcp_14068
crossref_primary_10_3390_ijms23010472
crossref_primary_10_3390_jcm10112231
crossref_primary_10_1016_j_ocarto_2022_100318
crossref_primary_10_1186_s13018_022_03293_0
crossref_primary_10_1186_s13018_020_01753_z
crossref_primary_10_20960_RevOsteoporosMetabMiner_00021
crossref_primary_10_2217_rme_2021_0032
crossref_primary_10_12677_ACM_2020_1012473
crossref_primary_10_1177_23259671241227863
crossref_primary_10_1186_s13018_024_05202_z
crossref_primary_10_1016_j_bioadv_2025_214272
crossref_primary_10_3390_bioengineering10111276
crossref_primary_10_3390_jcm11092640
crossref_primary_10_1007_s12178_024_09922_x
crossref_primary_10_1177_23259671211011948
crossref_primary_10_1007_s00264_020_04801_9
crossref_primary_10_1016_j_arthro_2024_03_002
crossref_primary_10_1186_s43055_024_01203_4
crossref_primary_10_3390_ijms20184581
crossref_primary_10_60118_001c_117195
crossref_primary_10_3390_jcm10081748
crossref_primary_10_1016_j_reth_2023_12_006
Cites_doi 10.1148/radiol.2303021388
10.1097/00008505-200110000-00002
10.1002/art.24925
10.1016/j.joca.2010.09.013
10.1136/bmjsem-2015-000060
10.1001/jama.2018.19319
10.1016/j.arthro.2014.02.020
10.1177/0269215517724193
10.1136/ard.2008.092015
10.1016/j.arthro.2016.09.024
10.1016/j.arthro.2016.12.006
10.1186/s10195-018-0501-3
10.5435/JAAOS-D-18-00305
10.7326/0003-4819-116-7-535
10.1016/j.arthro.2017.11.035
10.2214/AJR.16.16243
10.5435/00124635-200910000-00006
10.1136/bmjsem-2018-000442
10.1177/0363546510387517
10.1177/0363546515580787
10.1007/s00402-016-2545-2
10.15585/mmwr.mm6519a2
ContentType Journal Article
Copyright 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Distributed under a Creative Commons Attribution 4.0 International License
2019 by the authors. 2019
Copyright_xml – notice: 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: 2019 by the authors. 2019
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
1XC
VOOES
5PM
DOI 10.3390/ijms20061327
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database (ProQuest)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed

Publicly Available Content Database

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID PMC6472196
oai_HAL_inserm_02551116v1
30884774
10_3390_ijms20061327
Genre Journal Article
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M2O
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RPM
TR2
TUS
UKHRP
~8M
3V.
ABJCF
BBNVY
BHPHI
GROUPED_DOAJ
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
7XB
8FK
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
ESTFP
PUEGO
1XC
VOOES
5PM
ID FETCH-LOGICAL-c449t-e3156d6f9b44f583cf425931c6ac815b7323beaa842f5bd9cbe573f63f4779573
IEDL.DBID M48
ISSN 1422-0067
1661-6596
IngestDate Thu Aug 21 18:03:49 EDT 2025
Fri Sep 12 12:39:39 EDT 2025
Sat Sep 27 23:24:48 EDT 2025
Fri Jul 25 20:23:38 EDT 2025
Wed Feb 19 02:35:13 EST 2025
Tue Jul 01 01:45:36 EDT 2025
Thu Apr 24 23:06:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords growth factors
knee arthrosis
PRP
Language English
License https://creativecommons.org/licenses/by/4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c449t-e3156d6f9b44f583cf425931c6ac815b7323beaa842f5bd9cbe573f63f4779573
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC6472196
ORCID 0000-0003-1494-7011
0000-0001-6135-3078
OpenAccessLink https://www.proquest.com/docview/2332197113?pq-origsite=%requestingapplication%&accountid=15518
PMID 30884774
PQID 2332197113
PQPubID 2032341
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6472196
hal_primary_oai_HAL_inserm_02551116v1
proquest_miscellaneous_2194135219
proquest_journals_2332197113
pubmed_primary_30884774
crossref_citationtrail_10_3390_ijms20061327
crossref_primary_10_3390_ijms20061327
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-03-15
PublicationDateYYYYMMDD 2019-03-15
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-15
  day: 15
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2019
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Barbour (ref_2) 2016; 65
Felson (ref_3) 1992; 116
Brown (ref_8) 2013; 21
(ref_15) 2016; 136
Rastogi (ref_18) 2016; 207
Gregori (ref_7) 2018; 320
Castillo (ref_13) 2011; 39
Magalon (ref_12) 2014; 30
Dai (ref_10) 2017; 33
Zhang (ref_23) 2008; 67
Lisi (ref_21) 2018; 32
Graiet (ref_24) 2018; 13
Hunt (ref_11) 2017; 33
Riboh (ref_14) 2016; 44
Marx (ref_9) 2001; 10
Woertler (ref_22) 2004; 230
Chu (ref_16) 2019; 27
Hepper (ref_5) 2009; 17
Magalon (ref_17) 2016; 2
Lane (ref_1) 2011; 19
Bannuru (ref_6) 2009; 61
(ref_20) 2018; 19
Louis (ref_19) 2018; 34
Bellamy (ref_4) 2006; 19
References_xml – volume: 230
  start-page: 768
  year: 2004
  ident: ref_22
  article-title: Patellar articular cartilage lesions: in vitro MR imaging evaluation after placement in gadopentetate dimeglumine solution
  publication-title: Radiology
  doi: 10.1148/radiol.2303021388
– volume: 10
  start-page: 225
  year: 2001
  ident: ref_9
  article-title: Platelet-rich plasma (PRP): What is PRP and what is not PRP?
  publication-title: Implant Dent.
  doi: 10.1097/00008505-200110000-00002
– volume: 61
  start-page: 1704
  year: 2009
  ident: ref_6
  article-title: Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: A systematic review and meta-analysis
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.24925
– volume: 19
  start-page: 478
  year: 2011
  ident: ref_1
  article-title: OARSI-FDA initiative: Defining the disease state of osteoarthritis
  publication-title: Osteoarthr. Cartil.
  doi: 10.1016/j.joca.2010.09.013
– volume: 2
  start-page: e000060
  year: 2016
  ident: ref_17
  article-title: DEPA classification: A proposal for standardising PRP use and a retrospective application of available devices
  publication-title: BMJ Open Sport Exerc. Med.
  doi: 10.1136/bmjsem-2015-000060
– volume: 320
  start-page: 2564
  year: 2018
  ident: ref_7
  article-title: Association of Pharmacological Treatments with Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis
  publication-title: JAMA
  doi: 10.1001/jama.2018.19319
– volume: 30
  start-page: 629
  year: 2014
  ident: ref_12
  article-title: Characterization and comparison of 5 Platelet-Rich Plasma preparations in a single donor model
  publication-title: Arthroscopy
  doi: 10.1016/j.arthro.2014.02.020
– volume: 32
  start-page: 330
  year: 2018
  ident: ref_21
  article-title: Treatment of knee osteoarthritis: Platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial
  publication-title: Clin. Rehabil.
  doi: 10.1177/0269215517724193
– volume: 67
  start-page: 1716
  year: 2008
  ident: ref_23
  article-title: The placebo effect and its determinants in osteoarthritis: Meta-analysis of randomised controlled trials
  publication-title: Ann. Rheum Dis.
  doi: 10.1136/ard.2008.092015
– volume: 19
  start-page: CD005328
  year: 2006
  ident: ref_4
  article-title: Intraarticular corticosteroid for treatment of osteoarthritis of the knee
  publication-title: Cochrane Database Syst. Rev.
– volume: 33
  start-page: 659
  year: 2017
  ident: ref_10
  article-title: Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials
  publication-title: Arthroscopy
  doi: 10.1016/j.arthro.2016.09.024
– volume: 33
  start-page: 671
  year: 2017
  ident: ref_11
  article-title: Editorial Commentary: The Time Has Come to Try Intra-articular Platelet-Rich Plasma Injections for Your Patients with Symptomatic Knee Osteoarthritis
  publication-title: Arthroscopy
  doi: 10.1016/j.arthro.2016.12.006
– volume: 19
  start-page: 3
  year: 2018
  ident: ref_20
  article-title: Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: A randomized controlled trial
  publication-title: J. Orthop. Traumatol.
  doi: 10.1186/s10195-018-0501-3
– volume: 27
  start-page: e50
  year: 2019
  ident: ref_16
  article-title: Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations from the 2018 AAOS/NIH U-13 Conference
  publication-title: J. Am. Acad. Orthop. Surg.
  doi: 10.5435/JAAOS-D-18-00305
– volume: 116
  start-page: 535
  year: 1992
  ident: ref_3
  article-title: Weight loss reduces the risk for symptomatic knee osteoarthritis in woman. The Framingham Study
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-116-7-535
– volume: 34
  start-page: 1530
  year: 2018
  ident: ref_19
  article-title: Growth Factors Levels Determine Efficacy of Platelets Rich Plasma Injection in Knee Osteoarthritis: A Randomized Double Blind Noninferiority Trial Compared with Viscosupplementation
  publication-title: Arthroscopy
  doi: 10.1016/j.arthro.2017.11.035
– volume: 207
  start-page: 484
  year: 2016
  ident: ref_18
  article-title: Fundamentals of Joint Injection
  publication-title: Am. J. Roentgenol.
  doi: 10.2214/AJR.16.16243
– volume: 17
  start-page: 638
  year: 2009
  ident: ref_5
  article-title: The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: A systematic review of level I studies
  publication-title: J. Am. Acad. Orthop. Surg.
  doi: 10.5435/00124635-200910000-00006
– volume: 13
  start-page: e000442
  year: 2018
  ident: ref_24
  article-title: Use of platelet-rich plasma in regenerative medicine: Technical tools for correct quality control
  publication-title: BMJ Open Sport Exerc. Med.
  doi: 10.1136/bmjsem-2018-000442
– volume: 39
  start-page: 266
  year: 2011
  ident: ref_13
  article-title: Comparion of growth factor and platelet concentration from commercial platelet-rich plasma separation systems
  publication-title: Am. J. Sports Med.
  doi: 10.1177/0363546510387517
– volume: 44
  start-page: 792
  year: 2016
  ident: ref_14
  article-title: Effect of leukocyte concentration on the efficacy of Platelet rich Plasma in the treatment of knee osteoarthritis
  publication-title: Am. J. Sports Med.
  doi: 10.1177/0363546515580787
– volume: 136
  start-page: 1723
  year: 2016
  ident: ref_15
  article-title: Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis
  publication-title: Arch. Orthop. Trauma Surg.
  doi: 10.1007/s00402-016-2545-2
– volume: 65
  start-page: 489
  year: 2016
  ident: ref_2
  article-title: Prevalence of Doctor-Diagnosed Arthritis at State and County Levels—United States, 2014
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
  doi: 10.15585/mmwr.mm6519a2
– volume: 21
  start-page: 577
  year: 2013
  ident: ref_8
  article-title: AAOS clinical practice guidelines. Treatment of osteoarthritis of the knee: Evidence-based guideline, 2ded
  publication-title: J. Am. Acad. Orthop. Surg.
SSID ssj0023259
Score 2.4234674
Snippet Background: Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee...
Evidence is growing regarding the ability of platelet-rich plasma (PRP) injections to enhance functional capacity and alleviate pain in knee osteoarthritis...
Among them, platelet-rich plasma (PRP) is defined as an autologous plasma suspension of platelets, characterized by a platelet concentration higher than in...
SourceID pubmedcentral
hal
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1327
SubjectTerms Arthritis
Blood platelets
Growth factors
Life Sciences
Pain
Patients
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLa2Tki8IO6UDXSQ4AlFa2o7iZEQKmhTuZVoY2hvkZ04NNPmbGuLtL_BL-Yc58IKgrdEcZTLuX7253MYe16iFlg70gEGTxOIPNIBZvU2yEeh0ZGURVN4_vMsmh6JD8fyeIPNur0wRKvsfKJ31EWd0xz57phzNK44DPmb84uAukbR6mrXQkO3rRWK177E2CbbQpcsRwO29XZvlh70EIyPffu0EKNSEEkVNVR4jsB_tzo5WxC-RngWrwWpzTlRJP_OP_-kUV6LS_u32a02oYRJowF32IZ1d9mNpsXk1T328xBj06mF9-7Ek64c1CUQuQO-eb9Ep5OVb2JbrxaQri4tpAcppM0OvQVoOKy-OyIUoQygmYPwU4pQOfjorIUvqCg1auDc10d6BRO6udvBCUQ5wkwWaKMTEGvx6j472t_7-m4atH0YglwItQwsR5BXRKUyQpQy4XmJhq54iILNk1CamI-5sVonYlxKU6jcWBnzMuKliGOFhw_YwNXOPmKQaHRoKtE5oixhlFRS2pGRAkGhilC-Q_ay-_FZ3hYpp14ZpxmCFRJTdl1MQ_aiH33eFOf41ziUYT-EKmpPJ5-yyqGVn2WEqtDjRz_CIdvppJy1przIfivekD3rL6MR0sqKdhaFk-EATAak_4CHjVL0T-Pox_E_iCGL19Rl7XXWr7hq7gt9U2l_9JCP__9a2-wmZnGKiHGh3GGD5eXKPsFMaWmetur_CzPVE8Q
  priority: 102
  providerName: ProQuest
Title Single Injection of High Volume of Autologous Pure PRP Provides a Significant Improvement in Knee Osteoarthritis: A Prospective Routine Care Study
URI https://www.ncbi.nlm.nih.gov/pubmed/30884774
https://www.proquest.com/docview/2332197113
https://www.proquest.com/docview/2194135219
https://inserm.hal.science/inserm-02551116
https://pubmed.ncbi.nlm.nih.gov/PMC6472196
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFD5aNyHxgrgv26iMBE8o0NR2EiMhVNBKuY1oo6hvUZw6NFPnQi-I_g1-Mec4TbQykHipWsVRE5_rZ38-B-BRgVpgTCfzMXhqX-Rh5mNWb_y8E-gslHJcFZ7_eBIOhuLdSI52oO42upnAxV-hHfWTGs6nT39-X79Eg39BiBMh-7Py_GJByBiBVdSCPbdTRCQ-0ewnYNrg2qbRgodPDrqiwF-5eys4tSZEjbyad_5Jn7wUj_o34cYmkWS9SvK3YMfY23Ctai25vgO_zjAmTQ17a88d2cqyWcGI1MG-OH9EP3sr17wWsT9LVnPDktOEJdXJvAXL2Fn51RKRCOeeVWsPbimRlZa9t8awT6ggM9S8iauL9Jz16Ob65CYjqhFmsIwOODFiK67vwrB__Pn1wN_0X_BzIdTSNxzB3TgslBaikDHPCzRwxQMUaB4HUke8y7XJslh0C6nHKtdGRrwIeSGiSOHXe7BrZ9bsA4szdGQqznJEV0IrqaQ0HS0FgkEVotP04Ek98Wm-KU5OPTKmKYIUElN6WUwePG5Gf6uKcvxrHMqwGUKVtAe9D2lp0bovUkJT6OnDH4EHR7WU01oD0y7n-GBREHAPHjaX0fhoRyWzBoWT4gBUNule4H6lFM2_cfTfOA_Cg2hLXbYeZ_uKLSeuwDeV9EfPePCfr3kI1zGNU8SMC-QR7C7nK_MAU6WlbkMrGkX4GffftGHv1fFJctqm4CXbzj5-AxL6FtU
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB21qRC8IO64FFgk-oSsxt5dO4tUoQCtEpKGqDf1zaztdeOq3ZQmAeU3-CC-jRlfQgOCt77Z8sbeeM7OZX1mBuB1higwpqldNJ6xK5JAu-jVGzdperEOpEzLwvN7g6BzJD6dyJMV-FnnwhCtstaJhaJOxwntkW_5nOPiCj2Pv7v86lLXKPq6WrfQ0FVrhXS7KDFWJXb0zPw7hnCT7e5HlPem7-_uHH7ouFWXATcRQk1dwzGESYNMxUJkssWTDGGsuIfTTlqejEPu89ho3RJ-JuNUJbGRIc8CnokwVHiI912FNUEbKA1Ye78zGO4vQj7uF-3aPLSCbiBVUFLvOVfNrfzsYkLxPIaD4ZJRXB0RJfNvf_dP2uY1O7h7D-5WDixrl4i7DyvGPoBbZUvL-UP4cYC28Nywrj0rSF6WjTNGZBJ2XOhBOm3Piqa549mEDWdXhg33h2xYZgROmGYH-aklAhPKnJV7HsUWJsst61lj2GcE5hgRPyrqMb1lbfpxnTHKiOKEnjOjxCpGLMn5Izi6EYk8hoYdW_MUWEujAlUtnWBUJ2IllZSmGUuBQagKEE8OvKlffJRURdGpN8d5hMERiSm6LiYHNhejL8tiIP8ahzJcDKEK3p12P8otapWLiKI4tDDBN8-BjVrKUaU6JtFvoDvwanEZFz19ydHWoHAiHIDOhyz-wJMSFIuncbQb-B6EA-ESXJams3zF5qOisDi1EkCNvP7_ab2E253DvX7U7w56z-AOepCKSHme3IDG9GpmnqOXNo1fVEuBwZebXn2_AJ_6UFM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF21RSBeEHcMBQaJPiErsXfX9iIhFFGihJQSUYryZrzOmrhq16VOQPkNPoevY8aXtAHBW99seWNvPGdu67MzjD3PEAXGdBMXnad2RRokLkb1xk27nk4CKad14fn3-8HgULybyMkG-9XuhSFaZWsTK0M9LVJaI-_4nKNyhZ7HO1lDixjv9l-ffnOpgxR9aW3badQQGZnlD0zfylfDXZT1ju_33356M3CbDgNuKoSau4Zj-jINMqWFyGTE0wwhrLiHU04jT-qQ-1ybJImEn0k9Vak2MuRZwDMRhgoP8b6b7ErIhaC2EeHkPNnjftWozUP_5wZSBTXpnnPV7eRHJyVl8pgIhmvucHNGZMy_I90_CZsXPGD_JrvRhK7Qq7F2i20Ye5tdrZtZLu-wnwfoBY8NDO1RRe-yUGRANBL4XFlAOu0tqna5xaKE8eLMwPjjGMb1XsASEjjIv1qiLqG0oV7tqBYvIbcwssbAB4RkgVifVZWYXkKPftzuFQUiN2HMDLSlCogfubzLDi9FHvfYli2secAgStB0qihJMZ8TWkklpelqKTD9VAEiyWEv2hcfp005dOrKcRxjWkRiii-KyWE7q9GndRmQf41DGa6GUO3uQW8vzi3ak5OY8jf0LcF3z2HbrZTjxmiU8TnEHfZsdRnVnb7hJNagcGIcgGGHrP7A_RoUq6dx9Bj4HoTDwjW4rE1n_YrNZ1VJcWoigLb44f-n9ZRdQ52L94b7o0fsOoaOith4ntxmW_OzhXmM4dlcP6n0ANiXy1a833S8Te8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single+Injection+of+High+Volume+of+Autologous+Pure+PRP+Provides+a+Significant+Improvement+in+Knee+Osteoarthritis%3A+A+Prospective+Routine+Care+Study&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Guillibert%2C+Caroline&rft.au=Charpin%2C+Caroline&rft.au=Raffray%2C+Marie&rft.au=Benmenni%2C+Annie&rft.date=2019-03-15&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=20&rft.issue=6&rft.spage=1327&rft_id=info:doi/10.3390%2Fijms20061327&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms20061327
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon